GeneTether Therapeutics Inc. (CSE: GTTX) today announced that it has changed its name to Rize Oncology Inc. (“Rize” or the “Company”). This rebranding reflects the Company's strategic shift towards ...

Intensity Therapeutics, Inc. ("Intensity" or the "Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

1Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire. 2Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire.

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about losing her dominant arm to sarcoma and coping ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Sun Pharmaceuticals has emerged as a key speciality player, with global speciality revenues rising from 7% in FY18 to 18% in ...

The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...

CSE:GTTX) GeneTether Therapeutics Announces Closing of Licensing Agreement for STS-201 and $500,000 Non-Brokered Private Placement ...

An update from GeneTether Therapeutics, Inc. ( (TSE:GTTX) ) is now available.

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...